These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 28705917

  • 1. Curative Multicycle Radioimmunotherapy Monitored by Quantitative SPECT/CT-Based Theranostics, Using Bispecific Antibody Pretargeting Strategy in Colorectal Cancer.
    Cheal SM, Fung EK, Patel M, Xu H, Guo HF, Zanzonico PB, Monette S, Wittrup KD, Cheung NV, Larson SM.
    J Nucl Med; 2017 Nov; 58(11):1735-1742. PubMed ID: 28705917
    [Abstract] [Full Text] [Related]

  • 2. Theranostic pretargeted radioimmunotherapy of internalizing solid tumor antigens in human tumor xenografts in mice: Curative treatment of HER2-positive breast carcinoma.
    Cheal SM, Xu H, Guo HF, Patel M, Punzalan B, Fung EK, Lee SG, Bell M, Singh M, Jungbluth AA, Zanzonico PB, Piersigilli A, Larson SM, Cheung NV.
    Theranostics; 2018 Nov; 8(18):5106-5125. PubMed ID: 30429889
    [Abstract] [Full Text] [Related]

  • 3. Theranostic GPA33-Pretargeted Radioimmunotherapy of Human Colorectal Carcinoma with a Bivalent 177Lu-Labeled Radiohapten.
    Vaughn BA, Lee SG, Vargas DB, Seo S, Rinne SS, Xu H, Guo HF, Le Roux AB, Gajecki L, Krebs S, Yang G, Ouerfelli O, Zanzonico PB, Fung EK, St Jean S, Carrasco SE, Jungbluth A, Cheung NKV, Larson SM, Veach DR, Cheal SM.
    J Nucl Med; 2024 Oct 01; 65(10):1611-1618. PubMed ID: 39168519
    [Abstract] [Full Text] [Related]

  • 4. Theranostic pretargeted radioimmunotherapy of colorectal cancer xenografts in mice using picomolar affinity ⁸⁶Y- or ¹⁷⁷Lu-DOTA-Bn binding scFv C825/GPA33 IgG bispecific immunoconjugates.
    Cheal SM, Xu H, Guo HF, Lee SG, Punzalan B, Chalasani S, Fung EK, Jungbluth A, Zanzonico PB, Carrasquillo JA, O'Donoghue J, Smith-Jones PM, Wittrup KD, Cheung NV, Larson SM.
    Eur J Nucl Med Mol Imaging; 2016 May 01; 43(5):925-937. PubMed ID: 26596724
    [Abstract] [Full Text] [Related]

  • 5. Alpha radioimmunotherapy using 225Ac-proteus-DOTA for solid tumors - safety at curative doses.
    Cheal SM, McDevitt MR, Santich BH, Patel M, Yang G, Fung EK, Veach DR, Bell M, Ahad A, Vargas DB, Punzalan B, Pillarsetty NVK, Xu H, Guo HF, Monette S, Michel AO, Piersigilli A, Scheinberg DA, Ouerfelli O, Cheung NV, Larson SM.
    Theranostics; 2020 May 01; 10(25):11359-11375. PubMed ID: 33052220
    [Abstract] [Full Text] [Related]

  • 6. Preclinical evaluation of multistep targeting of diasialoganglioside GD2 using an IgG-scFv bispecific antibody with high affinity for GD2 and DOTA metal complex.
    Cheal SM, Xu H, Guo HF, Zanzonico PB, Larson SM, Cheung NK.
    Mol Cancer Ther; 2014 Jul 01; 13(7):1803-12. PubMed ID: 24944121
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pretargeted radioimmunotherapy and SPECT imaging of peritoneal carcinomatosis using bioorthogonal click chemistry: probe selection and first proof-of-concept.
    Rondon A, Schmitt S, Briat A, Ty N, Maigne L, Quintana M, Membreno R, Zeglis BM, Navarro-Teulon I, Pouget JP, Chezal JM, Miot-Noirault E, Moreau E, Degoul F.
    Theranostics; 2019 Jul 01; 9(22):6706-6718. PubMed ID: 31588245
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparative efficacy of 177Lu and 90Y for anti-CD20 pretargeted radioimmunotherapy in murine lymphoma xenograft models.
    Frost SH, Frayo SL, Miller BW, Orozco JJ, Booth GC, Hylarides MD, Lin Y, Green DJ, Gopal AK, Pagel JM, Bäck TA, Fisher DR, Press OW.
    PLoS One; 2015 Jul 01; 10(3):e0120561. PubMed ID: 25785845
    [Abstract] [Full Text] [Related]

  • 13. Dual Radionuclide Theranostic Pretargeting.
    Keinänen O, Brennan JM, Membreno R, Fung K, Gangangari K, Dayts EJ, Williams CJ, Zeglis BM.
    Mol Pharm; 2019 Oct 07; 16(10):4416-4421. PubMed ID: 31483993
    [Abstract] [Full Text] [Related]

  • 14. α- Versus β-Emitting Radionuclides for Pretargeted Radioimmunotherapy of Carcinoembryonic Antigen-Expressing Human Colon Cancer Xenografts.
    Heskamp S, Hernandez R, Molkenboer-Kuenen JDM, Essler M, Bruchertseifer F, Morgenstern A, Steenbergen EJ, Cai W, Seidl C, McBride WJ, Goldenberg DM, Boerman OC.
    J Nucl Med; 2017 Jun 07; 58(6):926-933. PubMed ID: 28232604
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Predictive patient-specific dosimetry and individualized dosing of pretargeted radioimmunotherapy in patients with advanced colorectal cancer.
    Schoffelen R, Woliner-van der Weg W, Visser EP, Goldenberg DM, Sharkey RM, McBride WJ, Chang CH, Rossi EA, van der Graaf WT, Oyen WJ, Boerman OC.
    Eur J Nucl Med Mol Imaging; 2014 Aug 07; 41(8):1593-602. PubMed ID: 24643780
    [Abstract] [Full Text] [Related]

  • 17. In vivo evaluation of pretargeted 64Cu for tumor imaging and therapy.
    Lewis MR, Wang M, Axworthy DB, Theodore LJ, Mallet RW, Fritzberg AR, Welch MJ, Anderson CJ.
    J Nucl Med; 2003 Aug 07; 44(8):1284-92. PubMed ID: 12902420
    [Abstract] [Full Text] [Related]

  • 18. Delivery of therapeutic doses of radioiodine using bispecific antibody-targeted bivalent haptens.
    Gautherot E, Le Doussal JM, Bouhou J, Manetti C, Martin M, Rouvier E, Barbet J.
    J Nucl Med; 1998 Nov 07; 39(11):1937-43. PubMed ID: 9829586
    [Abstract] [Full Text] [Related]

  • 19. Quantitative immuno-SPECT monitoring of pretargeted radioimmunotherapy with a bispecific antibody in an intraperitoneal nude mouse model of human colon cancer.
    Schoffelen R, van der Graaf WT, Sharkey RM, Franssen GM, McBride WJ, Chang CH, Bos DL, Goldenberg DM, Oyen WJ, Boerman OC.
    J Nucl Med; 2012 Dec 07; 53(12):1926-32. PubMed ID: 23081995
    [Abstract] [Full Text] [Related]

  • 20. Pretargeted radioimmunotherapy of colorectal cancer metastases: models and pharmacokinetics predict influence of the physical and radiochemical properties of the radionuclide.
    Frampas E, Maurel C, Remaud-Le Saëc P, Mauxion T, Faivre-Chauvet A, Davodeau F, Goldenberg DM, Bardiès M, Barbet J.
    Eur J Nucl Med Mol Imaging; 2011 Dec 07; 38(12):2153-64. PubMed ID: 21858527
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.